Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Sep 1;157(3):541-8.
doi: 10.1042/bj1570541.

The unactivated form of the first component of human complement, C1

The unactivated form of the first component of human complement, C1

I Gigli et al. Biochem J. .

Abstract

The first component of complement, C1, was isolated unactivated from human serum by repeated additions of di-isopropyl phosphorofluoridate during isolation. The unactivated subcomponents were also isolated, and evidence is given that the three subcomponents C1q, C1r and C1s account wholly for the activity of component C1 in serum. No evidence could be found for a fourth subcomponent, C1t. The approximate molar proportions of the subcomponents in serum are C1q/C1r/C1s = 1:2:2. Optimum activity by haemolytic assay was found at approximate molar proportions C1q/C1r/C1s of 1:4:4. No activity was found when subcomponents were assayed singly or in pairs, except for subcomponents C1q and C1s, which in molar ratio 1:4 gave 15-20% of the activity of the mixture C1q + C1r + C1s. The proteolytic activity of the isolated subcomponent C1s varied according to the method of activation used. Subcomponents C1q + C1r + C1s and C1q + C1s in the presence of antibody-antigen aggregates were activated and inactivated simultaneously, showing a peak of activity and subsequent loss of activity. Both reactions are probably due to proteolysis, and analysis of the peptide bonds split will be necessary to distinguish these two phenomena.

PubMed Disclaimer

References

    1. Proc Soc Exp Biol Med. 1956 May;92(1):32-7 - PubMed
    1. Immunochemistry. 1966 Mar;3(2):111-35 - PubMed
    1. J Exp Med. 1963 Jun 1;117:983-1008 - PubMed
    1. Biochem Soc Trans. 1976;4(1):127-9 - PubMed
    1. J Immunol. 1967 Aug;99(2):263-8 - PubMed

Publication types

MeSH terms